These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Selective cyclooxygenase-2 (COX-2) inhibitors: importance and limitations]. Pairet M, Netter P. Therapie; 1999 Nov; 54(4):433-45. PubMed ID: 10667110 [Abstract] [Full Text] [Related]
29. [Coxibs: cyclooxygenase-2 inhibitors]. Turnheim K. Wien Klin Wochenschr; 2001 Aug 16; 113(15-16):558-65. PubMed ID: 11571832 [Abstract] [Full Text] [Related]
30. The coxibs, selective inhibitors of cyclooxygenase-2. FitzGerald GA, Patrono C. N Engl J Med; 2001 Aug 09; 345(6):433-42. PubMed ID: 11496855 [No Abstract] [Full Text] [Related]
31. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents]. Chiolero A, Würzner G, Burnier M. Nephrologie; 2000 Aug 09; 21(8):425-30. PubMed ID: 11213386 [Abstract] [Full Text] [Related]
34. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL. Ann Intern Med; 2000 Jul 04; 133(1):1-9. PubMed ID: 10877734 [Abstract] [Full Text] [Related]
35. Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin. Brinker A, Goldkind L, Bonnel R, Beitz J. Drugs Aging; 2004 Jul 04; 21(7):479-84. PubMed ID: 15132714 [Abstract] [Full Text] [Related]
36. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?]. Bannwarth B. Gastroenterol Clin Biol; 2001 Apr 04; 25(4 Suppl):B79-84. PubMed ID: 11449148 [No Abstract] [Full Text] [Related]
38. [Specific inhibitors of cyclooxygenase type 2] ]. Tomasová-Studýnková J. Vnitr Lek; 2002 May 04; 48(5):403-8. PubMed ID: 12061207 [Abstract] [Full Text] [Related]
39. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Circulation; 2004 May 04; 109(17):2068-73. PubMed ID: 15096449 [Abstract] [Full Text] [Related]
40. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. Hochberg MC. Clin Exp Rheumatol; 2001 May 04; 19(6 Suppl 25):S15-22. PubMed ID: 11695246 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]